Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

COVID-19 infection may trigger alopecia areata in some patients.

The oral contraceptive improved hair and skin quality in women.

Low-dose oral minoxidil increases hair density and thickness in people with hair loss.

Media coverage increased public interest in oral minoxidil for hair loss but may also spread misinformation.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Oral minoxidil may effectively treat hair loss from chemotherapy.

More research is needed to see if non-English speakers are also more interested in oral minoxidil.

Low-dose oral minoxidil can help increase hair growth in women with hair loss.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

Oral and maxillofacial surgery has advanced with fluoride reducing tooth decay and high-speed handpieces aiding in more aesthetic procedures, leading to changes in practice and training.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Ketoconazole is effective for treating various fungal infections and has new uses in dermatology, but oral use can have serious side effects.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Nail loss may be a side effect of the MS drug teriflunomide.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Topical metformin shows promise for dental and skin treatments, including periodontitis, hair regrowth, wound healing, and acne.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.